Patient21 has picked up €100 million in the biggest funding round raised by a European health platform so far in 2023. This funding round was led by Israel’s largest venture capital fund Pitango that backed Magenta Medical and Ctrl recently, joined by Bertelsmann Investments and Artian, and supported by existing investors Target Global, Piton Capital, PICO Venture Partners, and several high-profile angel investors, including Mario Kohle and Maria Raga. Growth debt from IPF Partners, which constitutes a small part of the funding, has been secured to complement the equity raise.
Patient21 will use the investment to drive the development of its transformative software platform and expand from Germany into further European markets.
Patient21’s proprietary software stack covers every aspect of the patient’s experience from online booking, digital case history, check-in, diagnosis, and treatment planning to clinical quality control. The company has also started work on AI-driven diagnostic support.